Year |
Citation |
Score |
2023 |
Bonkovsky HL, Rudnick SP, Ma CD, Overbey JR, Wang K, Faust D, Hallberg C, Hedstrom K, Naik H, Moghe A, Anderson KE. Ledipasvir/Sofosbuvir Is Effective as Sole Treatment of Porphyria Cutanea Tarda with Chronic Hepatitis C. Digestive Diseases and Sciences. PMID 36811718 DOI: 10.1007/s10620-023-07859-8 |
0.354 |
|
2021 |
Ventura P, Bonkovsky HL, Gouya L, Aguilera-Peiró P, Bissell DM, Stein PE, Balwani M, Anderson DKE, Parker C, Kuter DJ, Monroy S, Oh J, Ritchie B, Ko JJ, Hua Z, et al. Efficacy and safety of givosiran for acute hepatic porphyria: 24-month interim analysis of the randomized phase 3 ENVISION study. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 34717041 DOI: 10.1111/liv.15090 |
0.308 |
|
2020 |
Rudnick S, Bonkovsky HL. Editorial: hepatitis C and porphyria cutanea tarda in 2020. Alimentary Pharmacology & Therapeutics. 51: 1432-1434. PMID 32445530 DOI: 10.1111/apt.15728 |
0.355 |
|
2020 |
Thapar M, Rudnick S, Bonkovsky HL. Givosiran, a novel treatment for acute hepatic porphyrias Expert Review of Precision Medicine and Drug Development. 6: 9-18. DOI: 10.1080/23808993.2021.1838275 |
0.303 |
|
2019 |
Sendi H, Mehrab-Mohseni M, Russo MW, Steuerwald N, Jacobs C, Clemens MG, Bonkovsky HL. Baseline Hepatic Levels of miR-29b and Claudin are Respectively Associated with the Stage of Fibrosis and HCV RNA in Hepatitis C. Clinical & Experimental Gastroenterology & Hepatology. 1. PMID 30957098 |
0.349 |
|
2015 |
O'Brien TR, Pfeiffer RM, Paquin A, Lang Kuhs KA, Chen S, Bonkovsky HL, Edlin BR, Howell CD, Kirk GD, Kuniholm MH, Morgan TR, Strickler HD, Thomas DL, Prokunina-Olsson L. Comparison of Functional Variants in IFNL4 and IFNL3 for Association with Hepatitis C Virus Clearance. Journal of Hepatology. PMID 26186989 DOI: 10.1016/J.Jhep.2015.06.035 |
0.364 |
|
2015 |
Sendi H, Mehrab-Mohseni M, Foureau DM, Ghosh S, Walling TL, Steuerwald N, Zamor PJ, Kaplan KJ, Jacobs C, Ahrens WA, Russo MW, Clemens MG, Schrum LW, Bonkovsky HL. MiR-122 decreases HCV entry into hepatocytes through binding to the 3' UTR of OCLN mRNA. Liver International : Official Journal of the International Association For the Study of the Liver. 35: 1315-23. PMID 25302477 DOI: 10.1111/Liv.12698 |
0.314 |
|
2013 |
Hou W, Bonkovsky HL. Non-coding RNAs in hepatitis C-induced hepatocellular carcinoma: dysregulation and implications for early detection, diagnosis and therapy. World Journal of Gastroenterology : Wjg. 19: 7836-45. PMID 24307777 DOI: 10.3748/wjg.v19.i44.7836 |
0.338 |
|
2013 |
Russo MW, Narang T, Eskind L, Hayes D, Casingal V, Purdum PP, Hanson JS, Ahrens W, Norton J, Bonkovsky H. Intravenous interferon administered during liver transplantation is not effective in preventing hepatitis C reinfection. Digestive Diseases and Sciences. 58: 3010-6. PMID 23812862 DOI: 10.1007/S10620-013-2749-Z |
0.344 |
|
2013 |
Ghosh S, Kaplan KJ, Schrum LW, Bonkovsky HL. Cytoskeletal proteins: shaping progression of hepatitis C virus-induced liver disease. International Review of Cell and Molecular Biology. 302: 279-319. PMID 23351713 DOI: 10.1016/B978-0-12-407699-0.00005-4 |
0.466 |
|
2013 |
O'Brien T, Pfeiffer R, Kuniholm M, Muchmore B, Aka P, Tang W, Chen S, Wang A, Astemborski J, Bonkovsky H, Edlin B, Howell C, Morgan T, Sharp G, Strickler H, et al. 2 A FRAME-SHIFT VARIANT IN THE NOVEL IFNL4 GENE IS ASSOCIATED WITH IMPAIRED HCV CLEARANCE Journal of Hepatology. 58: S1-S2. DOI: 10.1016/S0168-8278(13)60004-5 |
0.328 |
|
2012 |
Morishima C, Di Bisceglie AM, Rothman AL, Bonkovsky HL, Lindsay KL, Lee WM, Koziel MJ, Fontana RJ, Kim HY, Wright EC. Antigen-specific T lymphocyte proliferation decreases over time in advanced chronic hepatitis C. Journal of Viral Hepatitis. 19: 404-13. PMID 22571902 DOI: 10.1111/j.1365-2893.2011.01562.x |
0.378 |
|
2012 |
Ryan Caballes F, Sendi H, Bonkovsky HL. Hepatitis C, porphyria cutanea tarda and liver iron: an update. Liver International : Official Journal of the International Association For the Study of the Liver. 32: 880-93. PMID 22510500 DOI: 10.1111/J.1478-3231.2012.02794.X |
0.307 |
|
2012 |
Desai TK, Bortman J, Al-Sibae R, Bonkovsky H. The Role of Iron in Hepatitis C Infection Current Hepatitis Reports. 11: 41-47. DOI: 10.1007/S11901-011-0120-4 |
0.421 |
|
2011 |
Ghosh S, Ahrens WA, Phatak SU, Hwang S, Schrum LW, Bonkovsky HL. Association of filamin A and vimentin with hepatitis C virus proteins in infected human hepatocytes. Journal of Viral Hepatitis. 18: e568-77. PMID 21914078 DOI: 10.1111/J.1365-2893.2011.01487.X |
0.448 |
|
2011 |
O'Brien TR, Everhart JE, Morgan TR, Lok AS, Chung RT, Shao Y, Shiffman ML, Dotrang M, Sninsky JJ, Bonkovsky HL, Pfeiffer RM. An IL28B genotype-based clinical prediction model for treatment of chronic hepatitis C. Plos One. 6: e20904. PMID 21760886 DOI: 10.1371/journal.pone.0020904 |
0.333 |
|
2011 |
Mehrab-Mohseni M, Sendi H, Steuerwald N, Ghosh S, Schrum LW, Bonkovsky HL. Legalon-SIL downregulates HCV core and NS5A in human hepatocytes expressing full-length HCV. World Journal of Gastroenterology. 17: 1694-700. PMID 21483629 DOI: 10.3748/Wjg.V17.I13.1694 |
0.448 |
|
2010 |
Vuppalanchi R, Hayashi PH, Chalasani N, Fontana RJ, Bonkovsky H, Saxena R, Kleiner D, Hoofnagle JH. Duloxetine hepatotoxicity: a case‐series from the drug‐induced liver injury network Alimentary Pharmacology & Therapeutics. 32: 1174-1183. PMID 20815829 DOI: 10.1111/J.1365-2036.2010.04449.X |
0.341 |
|
2010 |
Fontana RJ, Dienstag JL, Bonkovsky HL, Sterling RK, Naishadham D, Goodman ZD, Lok AS, Wright EC, Su GL. Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C. Gut. 59: 1401-9. PMID 20675691 DOI: 10.1136/gut.2010.207423 |
0.31 |
|
2010 |
Hou W, Tian Q, Zheng J, Bonkovsky HL. MicroRNA-196 represses Bach1 protein and hepatitis C virus gene expression in human hepatoma cells expressing hepatitis C viral proteins. Hepatology (Baltimore, Md.). 51: 1494-504. PMID 20127796 DOI: 10.1002/hep.23401 |
0.394 |
|
2010 |
Zhang L, Wang G, Hou W, Li P, Dulin A, Bonkovsky HL. Contemporary clinical research of traditional chinese medicines for chronic hepatitis B in china: An analytical review Hepatology. 51: 690-698. PMID 20101751 DOI: 10.1002/hep.23384 |
0.33 |
|
2010 |
Snow KK, Bonkovsky HL, Fontana RJ, Kim HY, Sterling RK, Di Bisceglie AM, Morgan TR, Dienstag JL, Ghany MG. Changes in quality of life and sexual health are associated with low-dose peginterferon therapy and disease progression in patients with chronic hepatitis C. Alimentary Pharmacology & Therapeutics. 31: 719-34. PMID 20070284 DOI: 10.1111/j.1365-2036.2010.04235.x |
0.32 |
|
2010 |
Hou W, Tian Q, Zheng J, Bonkovsky HL. Zinc mesoporphyrin induces rapid proteasomal degradation of hepatitis C nonstructural 5A protein in human hepatoma cells. Gastroenterology. 138: 1909-19. PMID 19909748 DOI: 10.1053/j.gastro.2009.11.001 |
0.432 |
|
2010 |
O'Brien T, Bonkovsky H, Pfeiffer R, Chung R, Everhart J, Shiffman M, Sninsky J, Morgan T. 1174 ASSOCIATION OF IL28B GENOTYPE WITH VIROLOGICAL RESPONSE TO PEGYLATED-INTERFERON PLUS RIBAVIRIN IN PATIENTS WITH ADVANCED CHRONIC HEPATITIS C ENROLLED IN THE HALT-C TRIAL Journal of Hepatology. 52: S454. DOI: 10.1016/S0168-8278(10)61175-0 |
0.354 |
|
2010 |
Narang TK, Sendi H, Scobey MW, Bonkovsky HL. Iron and Hepatitis C Current Hepatitis Reports. 9: 169-177. DOI: 10.1007/S11901-010-0049-Z |
0.423 |
|
2009 |
Rustgi VK, Lee WM, Lawitz E, Gordon SC, Afdhal N, Poordad F, Bonkovsky HL, Bengtsson L, Chandorkar G, Harding M, McNair L, Aalyson M, Alam J, Kauffman R, Gharakhanian S, et al. Merimepodib, pegylated interferon, and ribavirin in genotype 1 chronic hepatitis C pegylated interferon and ribavirin nonresponders. Hepatology (Baltimore, Md.). 50: 1719-26. PMID 19852040 DOI: 10.1002/hep.23204 |
0.321 |
|
2009 |
Goodman ZD, Stoddard AM, Bonkovsky HL, Fontana RJ, Ghany MG, Morgan TR, Wright EC, Brunt EM, Kleiner DE, Shiffman ML, Everson GT, Lindsay KL, Dienstag JL, Morishima C. Fibrosis progression in chronic hepatitis C: morphometric image analysis in the HALT-C trial. Hepatology (Baltimore, Md.). 50: 1738-49. PMID 19824074 DOI: 10.1002/hep.23211 |
0.35 |
|
2009 |
Hou WH, Rossi L, Shan Y, Zheng JY, Lambrecht RW, Bonkovsky HL. Iron increases HMOX1 and decreases hepatitis C viral expression in HCV-expressing cells. World Journal of Gastroenterology. 15: 4499-510. PMID 19777608 DOI: 10.3748/WJG.15.4499 |
0.473 |
|
2009 |
Shiffman ML, Morishima C, Dienstag JL, Lindsay KL, Hoefs JC, Lee WM, Wright EC, Naishadham D, Everson GT, Lok AS, Di Bisceglie AM, Bonkovsky HL, Ghany MG. Effect of HCV RNA suppression during peginterferon alfa-2a maintenance therapy on clinical outcomes in the HALT-C trial. Gastroenterology. 137: 1986-94. PMID 19747918 DOI: 10.1053/j.gastro.2009.08.067 |
0.366 |
|
2009 |
Freedman ND, Everhart JE, Lindsay KL, Ghany MG, Curto TM, Shiffman ML, Lee WM, Lok AS, Di Bisceglie AM, Bonkovsky HL, Hoefs JC, Dienstag JL, Morishima C, Abnet CC, Sinha R, et al. Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C. Hepatology (Baltimore, Md.). 50: 1360-9. PMID 19676128 DOI: 10.1002/Hep.23162 |
0.303 |
|
2009 |
Everhart JE, Lok AS, Kim HY, Morgan TR, Lindsay KL, Chung RT, Bonkovsky HL, Ghany MG. Weight-related effects on disease progression in the hepatitis C antiviral long-term treatment against cirrhosis trial. Gastroenterology. 137: 549-57. PMID 19445938 DOI: 10.1053/j.gastro.2009.05.007 |
0.303 |
|
2009 |
Welzel TM, Morgan TR, Bonkovsky HL, Naishadham D, Pfeiffer RM, Wright EC, Hutchinson AA, Crenshaw AT, Bashirova A, Carrington M, Dotrang M, Sterling RK, Lindsay KL, Fontana RJ, Lee WM, et al. Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial. Hepatology (Baltimore, Md.). 49: 1847-58. PMID 19434718 DOI: 10.1002/hep.22877 |
0.399 |
|
2009 |
Lok AS, Everhart JE, Chung RT, Kim HY, Everson GT, Hoefs JC, Greenson JK, Sterling RK, Lindsay KL, Lee WM, Di Bisceglie AM, Bonkovsky HL, Ghany MG, Morishima C. Evolution of hepatic steatosis in patients with advanced hepatitis C: results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial. Hepatology (Baltimore, Md.). 49: 1828-37. PMID 19291787 DOI: 10.1002/hep.22865 |
0.376 |
|
2009 |
Fontana RJ, Bonkovsky HL, Naishadham D, Dienstag JL, Sterling RK, Lok AS, Su GL. Serum fibrosis marker levels decrease after successful antiviral treatment in chronic hepatitis C patients with advanced fibrosis. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. 7: 219-26. PMID 19068241 DOI: 10.1016/j.cgh.2008.10.034 |
0.319 |
|
2009 |
Bonifaz V, Shan Y, Lambrecht RW, Donohue SE, Moschenross D, Bonkovsky HL. Effects of silymarin on hepatitis C virus and haem oxygenase-1 gene expression in human hepatoma cells. Liver International : Official Journal of the International Association For the Study of the Liver. 29: 366-73. PMID 18694403 DOI: 10.1111/J.1478-3231.2008.01833.X |
0.507 |
|
2008 |
Di Bisceglie AM, Shiffman ML, Everson GT, Lindsay KL, Everhart JE, Wright EC, Lee WM, Lok AS, Bonkovsky HL, Morgan TR, Ghany MG, Morishima C, Snow KK, Dienstag JL. Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon. The New England Journal of Medicine. 359: 2429-41. PMID 19052125 DOI: 10.1056/NEJMoa0707615 |
0.319 |
|
2008 |
Chalasani N, Fontana RJ, Bonkovsky HL, Watkins PB, Davern T, Serrano J, Yang H, Rochon J. Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology. 135: 1924-34, 1934.e1-4. PMID 18955056 DOI: 10.1053/J.Gastro.2008.09.011 |
0.371 |
|
2008 |
Morgan TR, Lambrecht RW, Bonkovsky HL, Chung RT, Naishadham D, Sterling RK, Fontana RJ, Lee WM, Ghany MG, Wright EC, O'Brien TR. DNA polymorphisms and response to treatment in patients with chronic hepatitis C: results from the HALT-C trial. Journal of Hepatology. 49: 548-56. PMID 18619701 DOI: 10.1016/j.jhep.2008.05.011 |
0.414 |
|
2008 |
Lindsay KL, Morishima C, Wright EC, Dienstag JL, Shiffman ML, Everson GT, Lok AS, Bonkovsky HL, Lee WM, Morgan TR, Ghany MG. Blunted cytopenias and weight loss: new correlates of virologic null response to re-treatment of chronic hepatitis C. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. 6: 234-41. PMID 18237873 DOI: 10.1016/j.cgh.2007.11.020 |
0.418 |
|
2008 |
Seeff LB, Curto TM, Szabo G, Everson GT, Bonkovsky HL, Dienstag JL, Shiffman ML, Lindsay KL, Lok AS, Di Bisceglie AM, Lee WM, Ghany MG. Herbal product use by persons enrolled in the hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial. Hepatology (Baltimore, Md.). 47: 605-12. PMID 18157835 DOI: 10.1002/Hep.22044 |
0.352 |
|
2007 |
Shan Y, Zheng J, Lambrecht RW, Bonkovsky HL. Reciprocal effects of micro-RNA-122 on expression of heme oxygenase-1 and hepatitis C virus genes in human hepatocytes. Gastroenterology. 133: 1166-74. PMID 17919492 DOI: 10.1053/j.gastro.2007.08.002 |
0.379 |
|
2007 |
Sjogren MH, Sjogren R, Lyons MF, Ryan M, Santoro J, Smith C, Reddy KR, Bonkovsky H, Huntley B, Faris-Young S. Antiviral Response of HCV Genotype 1 to Consensus Interferon and Ribavirin Versus Pegylated Interferon and Ribavirin Digestive Diseases and Sciences. 52: 1540-1547. PMID 17406822 DOI: 10.1007/S10620-007-9757-9 |
0.512 |
|
2007 |
Lok AS, Everhart JE, Chung RT, Padmanabhan L, Greenson JK, Shiffman ML, Everson GT, Lindsay KL, Bonkovsky HL, Di Bisceglie AM, Lee WM, Morgan TR, Ghany MG, Morishima C. Hepatic steatosis in hepatitis C: comparison of diabetic and nondiabetic patients in the hepatitis C antiviral long-term treatment against cirrhosis trial. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. 5: 245-54. PMID 17296533 DOI: 10.1016/J.CGH.2006.11.002 |
0.411 |
|
2007 |
Shiffman ML, Ghany MG, Morgan TR, Wright EC, Everson GT, Lindsay KL, Lok AS, Bonkovsky HL, Di Bisceglie AM, Lee WM, Dienstag JL, Gretch DR. Impact of reducing peginterferon alfa-2a and ribavirin dose during retreatment in patients with chronic hepatitis C. Gastroenterology. 132: 103-12. PMID 17241864 DOI: 10.1053/j.gastro.2006.11.011 |
0.302 |
|
2006 |
Everson GT, Hoefs JC, Seeff LB, Bonkovsky HL, Naishadham D, Shiffman ML, Kahn JA, Lok AS, Di Bisceglie AM, Lee WM, Dienstag JL, Ghany MG, Morishima C. Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: Lessons from the HALT-C trial. Hepatology (Baltimore, Md.). 44: 1675-84. PMID 17133499 DOI: 10.1002/hep.21440 |
0.389 |
|
2006 |
Bonkovsky HL, Naishadham D, Lambrecht RW, Chung RT, Hoefs JC, Nash SR, Rogers TE, Banner BF, Sterling RK, Donovan JA, Fontana RJ, Di Bisceglie AM, Ghany MG, Morishima C. Roles of iron and HFE mutations on severity and response to therapy during retreatment of advanced chronic hepatitis C. Gastroenterology. 131: 1440-51. PMID 17101320 DOI: 10.1053/j.gastro.2006.08.036 |
0.342 |
|
2006 |
Morishima C, Morgan TR, Everhart JE, Wright EC, Shiffman ML, Everson GT, Lindsay KL, Lok AS, Bonkovsky HL, Di Bisceglie AM, Lee WM, Dienstag JL, Ghany MG, Gretch DR. HCV RNA detection by TMA during the hepatitis C antiviral long-term treatment against cirrhosis (Halt-C) trial. Hepatology (Baltimore, Md.). 44: 360-7. PMID 16871570 DOI: 10.1002/hep.21265 |
0.362 |
|
2006 |
Ghaziani T, Shan Y, Lambrecht RW, Donohue SE, Pietschmann T, Bartenschlager R, Bonkovsky HL. HCV proteins increase expression of heme oxygenase-1 (HO-1) and decrease expression of Bach1 in human hepatoma cells. Journal of Hepatology. 45: 5-12. PMID 16530877 DOI: 10.1016/j.jhep.2005.12.020 |
0.373 |
|
2006 |
Morishima C, Polyak SJ, Ray R, Doherty MC, Di Bisceglie AM, Malet PF, Bonkovsky HL, Sullivan DG, Gretch DR, Rothman AL, Koziel MJ, Lindsay KL. Hepatitis C virus-specific immune responses and quasi-species variability at baseline are associated with nonresponse to antiviral therapy during advanced hepatitis C. The Journal of Infectious Diseases. 193: 931-40. PMID 16518754 DOI: 10.1086/500952 |
0.442 |
|
2006 |
Alla V, Bonkovsky HL. Iron in nonhemochromatotic liver disorders. Seminars in Liver Disease. 25: 461-72. PMID 16315139 DOI: 10.1055/S-2005-923317 |
0.307 |
|
2006 |
Jamil LH, Desai T, Balasubramaniam M, Koff R, Bonkovsky H. Phlebotomy Improves Therapeutic Response to Interferon (INF) in Patients with Chronic Hepatitis C (CHC) American Journal of Gastroenterology. 101: S183. DOI: 10.14309/00000434-200609001-00415 |
0.344 |
|
2005 |
Polyak SJ, Sullivan DG, Austin MA, Dai JY, Shuhart MC, Lindsay KL, Bonkovsky HL, Di Bisceglie AM, Lee WM, Morishima C, Gretch DR. Comparison of amplification enzymes for Hepatitis C Virus quasispecies analysis. Virology Journal. 2: 41. PMID 15847697 DOI: 10.1186/1743-422X-2-41 |
0.392 |
|
2005 |
Giuggio VM, Bonkovsky HL, Rothman AL. Evolution of the intrahepatic T cell repertoire during chronic hepatitis C virus infection. Viral Immunology. 18: 179-89. PMID 15802962 DOI: 10.1089/VIM.2005.18.179 |
0.376 |
|
2005 |
Shan Y, Lambrecht RW, Bonkovsky HL. Association of hepatitis C virus infection with serum iron status: analysis of data from the third National Health and Nutrition Examination Survey. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 40: 834-41. PMID 15736017 DOI: 10.1086/428062 |
0.401 |
|
2005 |
Rothman AL, Morishima C, Bonkovsky HL, Polyak SJ, Ray R, Di Bisceglie AM, Lindsay KL, Malet PF, Chang M, Gretch DR, Sullivan DG, Bhan AK, Wright EC, Koziel MJ. Associations among clinical, immunological, and viral quasispecies measurements in advanced chronic hepatitis C. Hepatology (Baltimore, Md.). 41: 617-25. PMID 15726656 DOI: 10.1002/Hep.20581 |
0.47 |
|
2005 |
Sendi H, Ghaziani T, Zali MR, Adibi P, Agah M, Jazayeri M, Shahraz S, Magnius L, Bonkovsky HL. Hemochromatosis mutations in Iranians with hepatitis B virus infection. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 40: e19-21. PMID 15668853 DOI: 10.1086/426143 |
0.348 |
|
2004 |
Lee WM, Dienstag JL, Lindsay KL, Lok AS, Bonkovsky HL, Shiffman ML, Everson GT, Di Bisceglie AM, Morgan TR, Ghany MG, Morishima C, Wright EC, Everhart JE. Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonresponders. Controlled Clinical Trials. 25: 472-92. PMID 15465617 DOI: 10.1016/j.cct.2004.08.003 |
0.341 |
|
2004 |
Shiffman ML, Di Bisceglie AM, Lindsay KL, Morishima C, Wright EC, Everson GT, Lok AS, Morgan TR, Bonkovsky HL, Lee WM, Dienstag JL, Ghany MG, Goodman ZD, Everhart JE. Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment. Gastroenterology. 126: 1015-23; discussion . PMID 15057741 DOI: 10.1053/J.GASTRO.2004.01.014 |
0.402 |
|
2003 |
MORISHIMA C, RAY R, POLYAK S, SULLIVAN D, DIBISCEGLIE A, LEE W, BONKOVSKY H, GRETCH D, WRIGHT E, ROTHMAN A. 221 HCV-specific immune responses at baseline do not predict virologic response to antiviral therapy in advanced hepatitis C Hepatology. 38: 263-263. DOI: 10.1016/S0270-9139(03)80264-1 |
0.373 |
|
2002 |
Bonkovsky HL, Troy N, McNeal K, Banner BF, Sharma A, Obando J, Mehta S, Koff RS, Liu Q, Hsieh CC. Iron and HFE or TfR1 mutations as comorbid factors for development and progression of chronic hepatitis C Journal of Hepatology. 37: 848-854. PMID 12445428 DOI: 10.1016/S0168-8278(02)00305-7 |
0.352 |
|
2002 |
Mehta S, Levey JM, Bonkovsky HL. Extrahepatic manifestations of infection with hepatitis C virus. Clinics in Liver Disease. 5: 979-1008. PMID 11685805 DOI: 10.1016/S1089-3261(05)70205-1 |
0.369 |
|
2001 |
Bonkovsky HL, Stefancyk D, McNeal K, Banner BF, Liu Q, Zucker GM, Israel J, Stagias J, Colker J. Comparative effects of different doses of ribavirin plus interferon-alpha2b for therapy of chronic hepatitis C: results of a controlled, randomized trial. Digestive Diseases and Sciences. 46: 2051-9. PMID 11680575 DOI: 10.1023/A:1011919906194 |
0.352 |
|
2001 |
Bonkovsky HL, Mehta S. Hepatitis C: a review and update. Journal of the American Academy of Dermatology. 44: 159-82. PMID 11174373 DOI: 10.1067/MJD.2001.109311 |
0.353 |
|
2001 |
Bonkovsky HL, Mehta S. Hepatitis C: A review and update Disease-a-Month. 47: 610-647. DOI: 10.1016/S0011-5029(01)90007-0 |
0.314 |
|
2000 |
Szabo G, Katz E, Bonkovsky HL. Management of recurrent hepatitis C after liver transplantation: a concise review The American Journal of Gastroenterology. 95: 2164-2170. PMID 11007212 DOI: 10.1111/J.1572-0241.2000.02296.X |
0.32 |
|
2000 |
Di Bisceglie AM, Bonkovsky HL, Chopra S, Flamm S, Reddy RK, Grace N, Killenberg P, Hunt C, Tamburro C, Tavill AS, Ferguson R, Krawitt E, Banner B, Bacon BR. Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon: a multicenter, prospective, randomized, controlled trial. Hepatology (Baltimore, Md.). 32: 135-8. PMID 10869301 DOI: 10.1053/JHEP.2000.8700 |
0.426 |
|
2000 |
Fontana RJ, Israel J, LeClair P, Banner BF, Tortorelli K, Grace N, Levine RA, Fiarman G, Thiim M, Tavill AS, Bonkovsky HL. Iron reduction before and during interferon therapy of chronic hepatitis C: results of a multicenter, randomized, controlled trial. Hepatology (Baltimore, Md.). 31: 730-6. PMID 10706565 DOI: 10.1002/Hep.510310325 |
0.365 |
|
1999 |
Mathai J, Shimoda K, Banner BF, Mori M, Bonkovsky HL, Barnard GF. IFN-alpha receptor mRNA expression in a United States sample with predominantly genotype 1a/I chronic hepatitis C liver biopsies correlates with response to IFN therapy. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 19: 1011-8. PMID 10505743 DOI: 10.1089/107999099313226 |
0.421 |
|
1999 |
Heathcote EJL, James S, Mullen KD, Hauser SC, Rosenblate H, Albert DG, Bailey R, Bain VG, Bala K, Balart LA, Bonkovsky H, Black M, Cassidy WM, Donovan J, Ehrinpreis M, et al. Chronic hepatitis C virus patients with breakthroughs during interferon treatment can successfully be retreated with consensus interferon Hepatology. 30: 562-566. PMID 10421669 DOI: 10.1002/Hep.510300202 |
0.493 |
|
1999 |
Bonkovsky HL, Woolley JM. Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. The Consensus Interferon Study Group. Hepatology (Baltimore, Md.). 29: 264-70. PMID 9862876 DOI: 10.1002/HEP.510290124 |
0.342 |
|
1998 |
Giuggio VM, Bonkovsky HL, Smith J, Rothman AL. Inefficient recognition of autologous viral sequences by intrahepatic hepatitis C virus-specific cytotoxic T lymphocytes in chronically infected subjects. Virology. 251: 132-40. PMID 9813209 DOI: 10.1006/VIRO.1998.9401 |
0.406 |
|
1998 |
Banner BF, Karamitsios N, Smith L, Bonkovsky HL. Enhanced phenotypic expression of alpha-1-antitrypsin deficiency in an MZ heterozygote with chronic hepatitis C. The American Journal of Gastroenterology. 93: 1541-5. PMID 9732941 DOI: 10.1111/j.1572-0241.1998.00478.x |
0.359 |
|
1998 |
Bonkovsky HL, Poh-Fitzpatrick M, Pimstone N, Obando J, Di Bisceglie A, Tattrie C, Tortorelli K, LeClair P, Mercurio MG, Lambrecht RW. Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America. Hepatology (Baltimore, Md.). 27: 1661-9. PMID 9620340 DOI: 10.1002/HEP.510270627 |
0.428 |
|
1997 |
Jiang Z, Liu Y, Savas L, Smith L, Bonkovsky H, Baker S, Banner B. Frequency and distribution of DNA fragmentation as a marker of cell death in chronic liver diseases. Virchows Archiv : An International Journal of Pathology. 431: 189-94. PMID 9334840 DOI: 10.1007/s004280050087 |
0.3 |
|
1997 |
Banner BF, Allan C, Savas L, Baker S, Barnard G, Bonkovsky HL. Inflammatory markers in chronic hepatitis C. Virchows Archiv : An International Journal of Pathology. 431: 181-7. PMID 9334839 DOI: 10.1007/s004280050086 |
0.349 |
|
1997 |
Bonkovsky HL. Therapy of hepatitis C: other options. Hepatology (Baltimore, Md.). 26: 143S-151S. PMID 9305680 DOI: 10.1002/HEP.510260725 |
0.388 |
|
1995 |
Levey JM, Romain PL, Bonkovsky HL. Putting the freeze on hepatitis C virus-associated mixed cryoglobulinemia. Hepatology (Baltimore, Md.). 21: 594-7. PMID 7843735 DOI: 10.1002/HEP.1840210247 |
0.325 |
|
1995 |
Bonkovsky HL, Liang TJ, Hasegawa K, Banner B. Chronic leukocytoclastic vasculitis complicating HBV infection. Possible role of mutant forms of HBV in pathogenesis and persistence of disease. Journal of Clinical Gastroenterology. 21: 42-7. PMID 7560833 DOI: 10.1097/00004836-199507000-00011 |
0.36 |
|
1995 |
Barton AL, Banner BF, Cable EE, Bonkovsky HL. Distribution of iron in the liver predicts the response of chronic hepatitis C infection to interferon therapy American Journal of Clinical Pathology. 103: 419-424. PMID 7537017 |
0.301 |
|
1995 |
Clifford BD, Donahue D, Smith L, Cable E, Luttig B, Manns M, Bonkovsky HL. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C Hepatology. 21: 613-619. DOI: 10.1002/HEP.1840210302 |
0.322 |
|
1994 |
Levey JM, Bjornsson B, Banner B, Kuhns M, Malhotra R, Whitman N, Romain PL, Cropley TG, Bonkovsky HL. Mixed cryoglobulinemia in chronic hepatitis C infection. A clinicopathologic analysis of 10 cases and review of recent literature. Medicine. 73: 53-67. PMID 8309362 DOI: 10.1097/00005792-199401000-00005 |
0.445 |
|
1993 |
Cable EE, Cable JW, Bonkovsky HL. Repression of hepatic δ-aminolevulinate synthase by heme and metalloporphyrins: Relationship to inhibition of heme oxygenase Hepatology. 18: 119-127. DOI: 10.1002/HEP.1840180119 |
0.335 |
|
1989 |
Sinclair P, Frezza J, Sinclair J, Bement W, Haugen S, Healey J, Bonkovsky H. Immunochemical detection of different isoenzymes of cytochrome P-450 induced in chick hepatocyte cultures. Biochemical Journal. 258: 237-245. PMID 2930511 DOI: 10.1042/Bj2580237 |
0.33 |
|
1988 |
Bonkovsky HL, Healey JF, Lincoln B, Bacon BR, Bishop DF. Decreased Hepatic 5-Aminolevulinate Dehydrase in Experimental Hemochromatosis Annals of the New York Academy of Sciences. 526: 365-368. DOI: 10.1111/j.1749-6632.1988.tb55530.x |
0.358 |
|
1986 |
Bonkovsky HL, Blanchette PL, Schned AR. Severe liver injury due to phenelzine with unique hepatic deposition of extracellular material The American Journal of Medicine. 80: 689-692. PMID 3963046 DOI: 10.1016/0002-9343(86)90826-0 |
0.305 |
|
Show low-probability matches. |